Pharmafile Logo
Pharmafocus logo
Advanced Search

China

Showing 15 posts of 254 posts found.

Sanofi invests €66m in Chinese R&D hub

July 3, 2018
Manufacturing and Production China, Sanofi, chengdu, development, pharma, research

French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and …

News
opdivo_1_1

BMS’ Opdivo becomes first immuno-oncology agent available in China

June 18, 2018
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma

Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …

News
lilly_entrance_web

Eli Lilly partners with Chinese institution to advance the nation’s diabetes and CVD care

April 27, 2018
Medical Communications, Research and Development China, Eli Lilly, cardiovascular disorders, cvd, diabetes, pharma, type 2 diabetes

EIi Lilly has announced plans to partner up with China’s National Center for Cardiovascular Diseases (NCCD), the nation’s institution responsible …

News
mundipharma

Mundipharma signs Chinese licensing and distribution agreement with Grünenthal

January 16, 2018
Manufacturing and Production China, Grunenthal, Mundipharma, Tramal, pharma

US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on …

News
gilead-sciences

Gilead launches hep C drug Sovaldi in China at one-fifth of US price

November 29, 2017
Research and Development, Sales and Marketing China, Gilead, hepatitis C, pharma, sovaldi

Gilead has officially launched its hepatitis C drug Sovaldi (sofosbuvir) in the Chinese market, but with one major caveat: it …

News
800px-flag_of_the_peoples_republic_of_china

China to accelerate drug approvals with overseas trial data

October 9, 2017
Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals

In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …

News
fosun_pharma

China’s Fosun Group grabs 74% stake in India’s Gland Pharma for $1.1 billion

September 18, 2017
Sales and Marketing China, Fosun Pharma, Gland Pharma, India, pharma, pharmaceuticals

Chinese conglomerate Fosun has agreed to acquire 74% of India’s Gland Pharma for $1.1 billion, sealing a previously unsuccessful deal …

News
distribution

China’s distribution changes force major US company out

July 25, 2017
Manufacturing and Production, Sales and Marketing Cardinal Health, China, biotech, distribution, drugs, pharma, pharmaceutical

Cardinal Health, one of the largest drug distributors in the US, is looking to sell on its network in China, …

News
pollution

Superbugs in the supply chain

May 26, 2017
Medical Communications Antibiotics, Changing Markets, China, IMAGE: Changing Markets, Superbugs

Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from …

News
shutterstock_274590824

China threatens prison time and death penalty to fight fraudulent trial data

May 12, 2017
Medical Communications, Research and Development, Sales and Marketing China

In a drastic move to help solve its notorious problem with fraudulent clinical trial data, China has introduced a policy …

News
china_wall

China proposes ways to speed up approval for imported drugs

March 20, 2017
Sales and Marketing China, imported drugs

It can currently take up to three or four years for a new drug to reach market in China, slowing …

News
gdd_logo_002

BeiGene to develop $330 million biologics plant

March 7, 2017
Manufacturing and Production, Research and Development BeiGene, China, Guangzhou

BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …

News
the-chinese-national-flag-1752046_960_720

China’s insurance expansion boon to global pharma

February 23, 2017
Sales and Marketing AstraZeneca, China, GSK, Shire

China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …

News
medication

Generic version of top-selling lung cancer drug hits Chinese market

February 20, 2017
Sales and Marketing China, generics

A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …

News
shutterstock_57369385

WCO seizes 113m fake Indian & Chinese drugs in Africa in 10 days

February 3, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Africa, China, Counterfeit drugs, India, World Customs Organisation

The World Customs Organisation (WCO) has revealed insight into the extent of the global drug counterfeiting crisis with the announcement …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023